Monte Rosa Therapeutics, Inc. (GLUE)

20.14 +1.16 (+6.09%) USD  |  NASDAQ  |  Feb 23, 09:38
More

Monte Rosa Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Pfizer Inc. Upgrade
CorMedix, Inc. Upgrade
Zoetis, Inc. Upgrade
Alumis, Inc. Upgrade